Platform Technology
Development of drug delivery platforms that enhance both treatment convenience
and therapeutic efficacy
We are developing Next-generation delivery platforms that improve drug delivery efficiency
and sustain in vivo exposure, enabling a more patient-centric treatment experience.
Pipeline
Modality
Indication
Development Stage
IDC224
SC Platform
Breast cancer
PoC
IDC225
Ocular Platform
Undisclosed
Discovery
IDC226
SC Platform
Arthritis
PoC
IDC227
TASA™ Platform
Universal
PoC
Pipeline
IDC225